Nivo40-AVD for Advanced Classic Hodgkin Lymphoma
NCT06984146
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
54
Enrollment
OTHER
Sponsor class
Conditions
Hodgkin Lymphoma, Adult
Interventions
DRUG:
Nivolumab
DRUG:
Doxorubicin
DRUG:
Vinblastine
DRUG:
Dacarbazine
Sponsor
National Medical Research Radiological Centre of the Ministry of Health of Russia